Literature DB >> 8281097

Anticoagulation in patients with atrial fibrillation. Not safe and not cheap.

S M Rassam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8281097      PMCID： PMC1679499          DOI： 10.1136/bmj.307.6917.1492

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Survey of use of anticoagulation in patients with atrial fibrillation.

Authors:  P M Bath; A Prasad; M M Brown; G A MacGregor
Journal:  BMJ       Date:  1993-10-23

2.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

3.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

Authors:  M D Ezekowitz; S L Bridgers; K E James; N H Carliner; C L Colling; C C Gornick; H Krause-Steinrauf; J F Kurtzke; S M Nazarian; M J Radford
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

4.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors:  S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

5.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

6.  Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.

Authors:  C Gustafsson; K Asplund; M Britton; B Norrving; B Olsson; L A Marké
Journal:  BMJ       Date:  1992-12-12

7.  Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)

Authors:  P Sandercock; J Bamford; M Dennis; J Burn; J Slattery; L Jones; S Boonyakarnkul; C Warlow
Journal:  BMJ       Date:  1992-12-12
  7 in total
  1 in total

Review 1.  Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.

Authors:  K G Sweeney; D P Gray; R Steele; P Evans
Journal:  Br J Gen Pract       Date:  1995-03       Impact factor: 5.386
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.